ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Emerald Health Begins Enrollment for Systemic Sclerosis Treatment Study
August 03, 2020Emerald Health Pharmaceuticals (EHP) has begun enrollment and has dosed its first patients with diffuse cutaneous systemic sclerosis (dcSSc) in its Phase 2a clinical study of its lead product candidate, EHP-101. -
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung diseas
May 21, 2020Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic sclerosis-associated ILD (SSc-ILD).
Pharma Sources Insight January 2025
